- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Public goes ape over fibroid patient
When Beta, a 46-year-old gorilla from the Brookfield Zoo in Brookfield, IL, underwent uterine artery embolization for fibroids, some people took exception to her exceptional care.
When Beta, a 46-year-old gorilla from the Brookfield Zoo in Brookfield, IL, underwent uterine artery embolization for fibroids, some people took exception to her exceptional care.
A posting on the Wall Street Journal's health blog scoffed at a gorilla getting top-notch medical care while many humans do not. Initially, Dr. Steven Smith, one of the interventional radiologists on Beta's team, defended the action, as everybody was involved voluntarily. But the comment forced him to ponder why a gorilla could get access to better treatment than some women with uterine fibroids.
He admits that UAE is not the right treatment for everyone, but he questions what appears to be strong resistance from gynecologists to considering the benefits of the minimally invasive procedure. Criticism aside, he admits IRs occasionally get referrals from gynecologists.
"Beta the gorilla was a referral from a gynecologist," he said.
Comparing Digital Breast Tomosynthesis to Digital Mammography: What a Long-Term Study Reveals
September 17th 2024In a study involving over 272,000 breast cancer screening exams, digital breast tomosynthesis (DBT) had a higher breast cancer detection rate and a lower rate of advanced cancer presentation at the time of diagnosis in comparison to digital mammography.
Can Radiomics Enhance Differentiation of Intracranial Aneurysms on Computed Tomography Angiography?
September 17th 2024Radiomics models offered a pooled AUC of 86 percent for differentiating between ruptured and unruptured intracranial aneurysms, according to a recently published meta-analysis.
Emerging PSMA Radioligand Therapy Shows Benefits for Metastatic Castration-Resistant Prostate Cancer
September 16th 2024The PSMA-targeted modality 177Lu-PNT2002 improved radiographic progression-free survival by 29 percent in patients with mCRPC in comparison to ARPI therapy, according to new phase 3 trial data presented at the ESMO Congress in Spain.
The Nonexistence of Perfect Balance in Radiology
September 16th 2024In the elusive pursuit of reconciling case volume and having an appropriate number of radiologists, the proverbial windsurfer may fare better than stand-up paddleboarders and daredevil surfers at navigating the waves of the profession.
